What is the long-term trend for USANA Health Sciences's deferred compensation liability (non-current)?

Over 2 years (2022 to 2025), USANA Health Sciences's deferred compensation liability (non-current) has grown at a 92.1% compound annual growth rate (CAGR), from $1.63M to $6.02M.

USANA Health Sciences USNA Deferred Compensation Liability (Non-Current)

Deferred Compensation Liability (Non-Current) at other companies

Nature's Sunshine ProductsNATR

$1.28M+36.1%

BalchemBCPC

——

Other financials

Income statement

See full

Revenue$250.2M+0.3%

Gross profit$190.8M-3.2%

Operating income$13.9M-11.5%

Net income$7.5M-20.1%

EPS (diluted)$0.41-16.3%

Balance sheet

See full

Cash & equivalents$165.7M-9.2%

Total debt$18.0M+10.8%

Total equity$543.6M+2.6%

Total assets$739.0M-1.0%

Cash flow

See full

Operating cash flow$9.8M-37.0%

CapEx$2.6M-5.6%

Free cash flow$7.1M-43.9%

Valuation

See full

Market cap$363.35M-36.1%

P/E18.1×+7.8×

P/S0.4×-0.3×

Profitability

See full

Gross margin77.6%-3.0pp

Operating margin3.8%-2.7pp

Net margin1.9%-4.4pp

FCF margin5.7%-1.1pp

Returns & leverage

See full

Return on equity3.2%-7.6pp

Debt / equity0×0.0×

Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's deferred compensation liability (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is USANA Health Sciences's deferred compensation liability (non-current)?: USANA Health Sciences (USNA) reported deferred compensation liability (non-current) of $5.68M in Q1 2026.
What is the long-term trend for USANA Health Sciences's deferred compensation liability (non-current)?: Over 2 years (2022 to 2025), USANA Health Sciences's deferred compensation liability (non-current) has grown at a 92.1% compound annual growth rate (CAGR), from $1.63M to $6.02M.